“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part IV
Apr 8, 2019
Big Pharma has tried to evade culpability for the crisis of rising… Read More
© 2026 CSRXP- All Rights Reserved
Blog Posts
“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part III
Apr 7, 2019
Big Pharma has tried to evade culpability for the crisis of rising… Read More
Second Opinion: Rebate Rule Would be Revolutionary … For Big Pharma
Apr 5, 2019
Nothing in Proposed Rule Guarantees Prices Will Come Down by Full Amount of… Read More
“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part II
Apr 5, 2019
Big Pharma has tried to evade culpability for the crisis of rising… Read More
“DOSE OF REALITY” Calling Big Pharma’s Bluff On PBMs: Part I
Apr 4, 2019
Big Pharma has tried to evade culpability for the crisis of rising… Read More
THEY SAID IT! Lawmakers Blast Insulin Price Hikes, Call For Drug Price Action And Question The Rebate Rule
Apr 3, 2019
On Tuesday, the U.S. House Committee on Energy and Commerce Subcommittee on… Read More
They Said It! Lawmakers Advance Key Drug Pricing Bills
Mar 28, 2019
House Energy & Commerce Members Recommit To Bipartisan Action As Critical… Read More
Second Opinion: Rebate Rule Will Hike Premiums On Seniors
Mar 12, 2019
Lowering prescription drug prices is a laudable focus of the Trump… Read More
THEY SAID IT! U.S. House Ways & Means Subcommittee Pushes For Increased Competition To Lower Drug Prices
Mar 8, 2019
On Thursday, members of the U.S. House Committee on Ways and Means… Read More
THEY SAID IT! Senators On Aging Committee Join Call For Action In Washington To Alleviate Rising Burden Of Prescription Drug Prices
Mar 6, 2019
On Wednesday, five American patients gave eye-opening testimony to members of… Read More
Headlines: Big Pharma Reboots Tired Tactics During Hill Grilling
Feb 28, 2019
Testimony from Seven Drug Makers Showcases Continued Unwillingness to Take… Read More
They Said It: Senators Slam Big Pharma CEOs For Price Gouging, Anti-Competitive Tactics
Feb 27, 2019
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on… Read More